Qiagen N.V. (FRA:QIA)

Market Cap	9.11B
Revenue (ttm)	1.74B
Net Income (ttm)	317.94M
Shares Out	n/a
EPS (ttm)	1.44
PE Ratio	28.66
Forward PE	20.23
Dividend	1.42 (3.48%)
Ex-Dividend Date	Jul 2, 2025

Volume	500
Average Volume	613
Open	41.30
Previous Close	40.85
Day's Range	40.86 - 41.36
52-Week Range	32.50 - 47.53
Beta	n/a
RSI	49.78
Earnings Date	Jul 28, 2025

About Silk Road Medical

Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally. The company offers primary sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, such as kits and components for purification of nucleic acids; and...

• Industry: Laboratory Analytical Instruments
• Founded: 1984
• Employees: 5,396
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: QIA

Financial Performance

In 2024, Qiagen's revenue was $1.98 billion, an increase of 0.66% compared to the previous year's $1.97 billion. Earnings were $83.59 million, a decrease of -75.51%.